BVS - Bioventus Inc logo

Bioventus Inc

BVS

Bioventus Inc. develops medical devices focused on musculoskeletal therapies, offering products such as hyaluronic acid injections, peripheral nerve stimulation devices, ultrasonic surgical systems, and bone graft substitutes for pain relief and recovery.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$979today

Score Overview

1 Year
Score
Net Growth139.59%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth2.42%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.2
Net Growth181.10%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth35.03%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth181.10%
Net Trend80%
Net Income Consistency
Rev Growth35.03%
Rev Trend80%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Bioventus Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. BVS does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 14.96โ€”
1 Year2025-10-23
$ 6.96114.94%
5 Years2021-10-22
$ 15.28-2.09%
All Time2021-02-11
$ 19.21-22.12%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 581M$ 54M$ 29M
2025$ 568M$ 22M$ 51M
2024$ 573M-$ 33M$ 41M
2023$ 512M-$ 156M$ 36M
2022$ 512M-$ 158M$ 30M
IPO2021$ 430M$ 19M$ 43M
BVS - Bioventus Inc logo

Bioventus Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 430M to $ 568M and net income grew from $ 19M to $ 22M. Revenue increased in 80% of the years measured; net income in 80%.

Bioventus Inc currently holds a 5-year HDB Score of 7.2 out of 10. How the HDB Score is calculated.

Membership

Explore BVS with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies